Growth differentiation factor (GDF) for treatment of diastolic heart failure
Abstract:
The methods and uses described herein relate to the treatment of age-related conditions, e.g. by administering an agent that inhibits the interaction of GDF11 and follistatin. In some embodiments, the agent can bind to an epitope of GDF11 as described herein.
Information query
Patent Agency Ranking
0/0